United States · FDA National Drug Code directory

TERIFLUNOMIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
46708-313_5c2a05ed-ff36-4dce-97e9-77b2d948b4f0
Product NDC
46708-313
Form
TABLET, FILM COATED
Composition / generic term
TERIFLUNOMIDE
Labeler
Alembic Pharmaceuticals Limited
Marketing category
ANDA
Marketing start / end (source format)
20230125
Source listing expiry
20261231

Source-listed ingredients

  • TERIFLUNOMIDE — 7 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 2 BLISTER PACK in 1 CARTON (46708-313-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK · 46708-313-14
  • 30 TABLET, FILM COATED in 1 BOTTLE (46708-313-30) · 46708-313-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →